A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons.

The recent progress in stem cell techniques has broadened the horizon for in vitro disease modeling. For desired in vivo like phenotypes, not only correct cell type specification will be critical, the microenvironmental context will be essential to achieve relevant responses. We demonstrate how a three dimensional (3D) culture of stem cell derived neurons can induce in vivo like responses related to Alzheimer's disease, not recapitulated with conventional 2D cultures. To acquire a neural population of cells we differentiated neurons from neuroepithelial stem cells, derived from induced pluripotent stem cells. p21-activated kinase mediated sensing of Aβ oligomers was only possible in the 3D environment. Further, the 3D phenotype showed clear effects on F-actin associated proteins, connected to the disease processes. We propose that the 3D in vitro model has higher resemblance to the AD pathology than conventional 2D cultures and could be used in further studies of the disease.

[1]  Mark W. Tibbitt,et al.  Dynamic Microenvironments: The Fourth Dimension , 2012, Science Translational Medicine.

[2]  M. Nikolic.  The Pak1 Kinase: An Important Regulator of Neuronal Morphology and Function in the Developing Forebrain , 2008, Molecular Neurobiology.

[3]  Matthew Trotter,et al.  Capture of Neuroepithelial-Like Stem Cells from Pluripotent Stem Cells Provides a Versatile System for In Vitro Production of Human Neurons , 2012, PloS one.

[4]  G. Cole,et al.  PAK in Alzheimer disease, Huntington disease and X-linked mental retardation , 2012, Cellular logistics.

[5]  Shuguang Zhang,et al.  Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold , 2009, Proceedings of the National Academy of Sciences.

[6]  G. Lubec,et al.  Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome , 2002, Neuroscience Letters.

[7]  Michel Labouesse,et al.  A tension-induced mechanotransduction pathway promotes epithelial morphogenesis , 2011, Nature.

[8]  Sang-Hoon Lee,et al.  Size-controllable networked neurospheres as a 3D neuronal tissue model for Alzheimer's disease studies. , 2013, Biomaterials.

[9]  Kristopher L. Nazor,et al.  Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.

[10]  Adam J. Engler,et al.  Matrix elasticity directs stem cell differentiation , 2006 .

[11]  H. Okano,et al.  [Modeling familial Alzheimer's disease with induced pluripotent stem cells]. , 2012, Rinsho shinkeigaku = Clinical neurology.

[12]  C. Duyckaerts,et al.  Alzheimer disease models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.

[13]  Johanna Huttenlocher-Moser.  Variant of TREM2 Associated with the Risk of Alzheimer's Disease , 2013 .

[14]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[15]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[16]  Olle Inganäs,et al.  The promotion of neuronal maturation on soft substrates. , 2009, Biomaterials.

[17]  Jochen Guck,et al.  Mechanics in neuronal development and repair. , 2013, Annual review of biomedical engineering.

[18]  G. Cole,et al.  p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis* , 2008, Journal of Biological Chemistry.

[19]  Laura Ylä-Outinen,et al.  Three‐dimensional growth matrix for human embryonic stem cell‐derived neuronal cells , 2014, Journal of tissue engineering and regenerative medicine.

[20]  A. Rich,et al.  Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Chilton,et al.  Targeting of the F-actin-binding protein drebrin by the microtubule plus-tip protein EB3 is required for neuritogenesis , 2008, Nature Cell Biology.

[22]  S. Orkin,et al.  A Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome , 2012, Science Translational Medicine.

[23]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[24]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[25]  D. Cotanche,et al.  Peptide- and collagen-based hydrogel substrates for in vitro culture of chick cochleae. , 2008, Biomaterials.

[26]  A. Robitzki,et al.  Induced Tauopathy in a Novel 3D-Culture Model Mediates Neurodegenerative Processes: A Real-Time Study on Biochips , 2012, PloS one.

[27]  Katsuhiro Yoshikawa,et al.  Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. , 2013, Cell stem cell.

[28]  M. Warr,et al.  Metabolic makeover for HSCs. , 2013, Cell stem cell.

[29]  B. Teter,et al.  Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease , 2006, Nature Neuroscience.

[30]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[31]  R. Maccioni,et al.  Fibrillar amyloid-β1-42 modifies actin organization affecting the cofilin phosphorylation state: a role for Rac1/cdc42 effector proteins and the slingshot phosphatase. , 2012, Journal of Alzheimer's disease : JAD.

[32]  篠原 隆司,et al.  Induction of pluripotent stem cell cells from germ cells , 2012 .

[33]  J. Bamburg,et al.  ADF/cofilin and actin dynamics in disease. , 2002, Trends in cell biology.